Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Sales (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Return on Sales for 6 consecutive years, with 1.11% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 7.0% to 1.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.4% through Dec 2025, up 27.0% year-over-year, with the annual reading at 1.4% for FY2025, 27.0% up from the prior year.
  • Return on Sales hit 1.11% in Q4 2025 for Rapid Micro Biosystems, up from 1.47% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.11% in Q4 2025 to a low of 4.42% in Q1 2021.
  • Historically, Return on Sales has averaged 2.46% across 5 years, with a median of 2.28% in 2023.
  • Biggest five-year swings in Return on Sales: tumbled -771bps in 2021 and later skyrocketed 200bps in 2023.
  • Year by year, Return on Sales stood at 2.8% in 2021, then crashed by -34bps to 3.76% in 2022, then soared by 53bps to 1.76% in 2023, then skyrocketed by 33bps to 1.18% in 2024, then grew by 6bps to 1.11% in 2025.
  • Business Quant data shows Return on Sales for RPID at 1.11% in Q4 2025, 1.47% in Q3 2025, and 1.63% in Q2 2025.